| Course | NR 580 Adult-Gerontology Primary Care Capstone and Intensive |
|---|---|
| Week | 4 |
| Paper type | Clinical decision brief |
| Length | About 1,120 words, 6 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | MSN, Adult-Gerontology Primary Care NP (AGPCNP) |
| Updated | October 2026 |
Free sample paper for NR 580 Week 4
Clinical Decision Brief: Stop Glipizide and Reduce Insulin, or Keep the A1c Near 6.4%, for a 76-Year-Old Who Falls, With the Alternative Given Its Real Case
Student Name
College of Nursing, Chamberlain University
NR 580: Adult-Gerontology Primary Care Capstone and Intensive
Instructor Name
Month Day, Year
Clinical Decision Brief: Stop Glipizide and Reduce Insulin, or Keep the A1c Near 6.4%, for a 76-Year-Old Who Falls, With the Alternative Given Its Real Case
The Decision
Option A: stop glipizide, reduce insulin glargine from 24 to 16 units and accept an A1c that may rise to between 7% and 8%. Option B: keep both medicines, add a bedtime snack and continuous glucose monitoring to prevent the low sugars, and keep the A1c near its current 6.4%.
The Facts That Bear on This Choice
Three low sugars in six weeks, all overnight, one followed by a fall. A1c 6.4%. Age 76. Kidney function at stage 3b, which slows the clearance of both glipizide's active forms and insulin. Heart failure and orthostatic hypotension, which make every fall more likely and every hypoglycemic event more dangerous. Mild cognitive impairment, with the spouse managing medicines. The patient's own priority is to stop falling, even at the price of a higher number.
Facts from the case that do not bear on this decision, such as the heart failure medicine doses, are left out of this brief and handled elsewhere.
The Case for Option B, Taken Seriously
Option B has real arguments. The A1c of 6.4% means the patient's average glucose is well controlled, and a rise toward 8% carries some long-term risk of small-vessel complications. Continuous glucose monitoring could catch overnight lows and allow the doses to be fine-tuned rather than cut. A bedtime snack might prevent the 03:00 drop. The patient has had diabetes for 21 years and has never had a kidney or eye complication severe enough to cause symptoms, which some would read as a reason to keep doing what has worked.
Why Option A Is Chosen
Three reasons. First, time to benefit. Tight glucose control reduces small-vessel complications over many years, while the harm of hypoglycemia, a fall, an injury, a heart rhythm problem, arrives tonight. For a 76-year-old with heart failure and kidney disease, the years needed for the benefit of an A1c of 6.4% over one of 7.5% are unlikely to be available.
Second, evidence. When a large trial pushed glucose very low in people with long-standing diabetes at high risk of heart disease, the intensive group had more deaths and more severe hypoglycemia, and that arm was stopped early (Action to Control Cardiovascular Risk in Diabetes Study Group, 2008). In a national sample, about a quarter of older adults with diabetes were held to tight targets with insulin or sulfonylureas, which the authors describe as potential overtreatment (Lipska et al., 2015). The Beers panel lists sulfonylureas among drugs to avoid in later life, since the low sugars they cause can last for hours (American Geriatrics Society Beers Criteria Update Expert Panel, 2023).
Third, the patient's own priority, which is to stop falling.
Option B treats the low sugars as a monitoring problem when they are a dosing problem. Continuous monitoring would show the lows more clearly but would not stop them, and it would add a device to a household already managing six medicines. It would also leave glipizide in place, a drug the prescribing criteria single out for older adults.
What Option A Costs
The A1c will probably rise. If it goes above 8%, glucose-related symptoms or infections may become more likely, and a medicine with a low risk of hypoglycemia may need to be added. Option A also gives up some long-term protection against small-vessel complications, which the patient accepted.
Who Was Involved in the Decision
The patient and spouse made the decision with me and my preceptor in the room. The patient chose Option A after hearing both options described, saying: "I'd rather have a higher sugar than another night on the bathroom floor." The spouse asked about the risks of a higher sugar, and I explained that the main short-term risks are thirst, infections and fatigue, which would be watched for. My preceptor agreed with the reasoning and cosigned the note without change.
Why the Alternative Is Not Wrong for Everyone
Option B would suit a different patient: a younger adult without falls, with a long life expectancy and good kidney function, for whom continuous monitoring could allow tight control safely. The brief chooses Option A for this patient, not as a general rule about older adults.
How the Decision Will Be Checked
Overnight glucose checks twice a week for two weeks; A1c at three months; any reading below 70 prompts a further glargine reduction; any reading above 300 prompts a call, and the spouse has both the clinic number and the after-hours line written on the refrigerator. If the A1c rises above 8.5%, the next step is a low-risk agent rather than restarting glipizide.
What the Evidence Does Not Settle
The trial evidence comes from adults with high cardiovascular risk, many younger than this patient, and from a target of an A1c below 6% rather than this patient's 6.4%. It supports caution about intensive control in people like this patient, but it does not prove that this patient's current control caused harm beyond the low sugars themselves. The decision rests as much on the patient's own low sugars and falls as on the trial.
A Second Opinion Considered
My preceptor suggested a middle course: stop glipizide but leave the insulin unchanged and see whether the lows stop. I considered it. With kidney function at 38 and all three lows overnight, when glargine is acting and glipizide's effect from supper is fading, I judged that both drugs were contributing. Stopping one would leave the patient exposed for another two weeks. My preceptor agreed with the reasoning, and the note records the alternative.
The Patient's View, Stated Plainly
The patient did not want to talk about numbers. The patient wanted to know whether the change would stop the nights on the bathroom floor. That question, more than the A1c, is the one the decision answers.
The Decision in One Sentence
Stop glipizide and reduce glargine, accepting a higher A1c, because the patient's low sugars and falls are present now and the benefit of tight control would take years this patient may not have.
What This Brief Does Not Decide
It does not decide the heart failure medicines or the SGLT2 inhibitor, which have their own brief, and it does not decide whether the patient should continue to manage insulin at home given cognition, which is being watched.
References
Action to Control Cardiovascular Risk in Diabetes Study Group. (2008). Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine, 358(24), 2545-2559. https://doi.org/10.1056/NEJMoa0802743
American Geriatrics Society Beers Criteria Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71(7), 2052-2081. https://doi.org/10.1111/jgs.18372
Lipska, K. J., Ross, J. S., Miao, Y., Shah, N. D., Lee, S. J., & Steinman, M. A. (2015). Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Internal Medicine, 175(3), 356-362. https://doi.org/10.1001/jamainternmed.2014.7345
NR 580 Week 4 instructions, in plain terms
The Week 4 brief should be short and load-bearing, two or three pages in which almost every sentence does work. Open on the decision itself in a single line, phrased as a choice between named options rather than as a conclusion. Include only the parts of the case that bear on this one choice. The alternative needs real treatment, because a choice with no cost was never a decision. Most rubrics also want the cost of the chosen option named and a way of checking whether it was right. The decision should be one that other parts of the plan depend on, not a safe choice picked because it is easy to argue.
How this NR 580 Week 4 example is built
The brief opens with two options: stop glipizide and reduce insulin, or keep both with a snack and continuous monitoring. A section lists the facts that bear on the choice and says which facts were left out. The case for keeping tight control is made fairly. Three reasons for deintensifying follow: time to benefit, trial and prescribing evidence and the patient's priority. The cost of the choice is named. A section records who was involved and why the rejected option would suit a different patient. Limits of the evidence, a middle course proposed by the preceptor, the patient's view, a one-sentence decision and a checking plan follow.
NR 580 Week 4 rubric: what full points look like
The deepest loss is a brief defending a decision nothing else depends on, chosen because it was easy to argue; this one decides the glucose plan that the falls and heart failure decisions rest on. Running it close is an argument made only for the chosen option, with the alternative dismissed in half a sentence; here the alternative gets its own section. Findings imported from the case that do not bear on the choice cost points, so the brief names what it leaves out. Naming the cost of the choice earns the trade-off row, and a checking plan with thresholds completes it.
NR 580 Week 4 help from the desk
Weak NR 580 Week 4 briefs argue an uncontroversial decision. Others dismiss the alternative in a line. Many paste in the whole case instead of the facts that bear on the choice. Costs of the chosen option are rarely stated. Some briefs end without a way to know whether the decision was right. If your decision differs, send the two options and the facts that matter, and a brief can be laid out that gives the alternative a fair hearing and names what the choice gives up. Write the decision as two named options in the first line, keep only the facts that bear on it, and say in a sentence what your choice gives up and how you will know if it was wrong.
Get a NR 580 Week 4 example written to your instructions
Send the Week 4 prompt, the rubric your classroom posts and the case or scenario you were handed, and a custom example is written against those and returned inside 24 to 48 hours, with the first one free. It arrives as a finished brief, reversal section included, for you to read your own argument beside.
More NR 580 papers and AGPCNP samples
- NR 580 Week 1: Entrustment Claim Discussion Post
- NR 580 Week 2: Capstone Case Presentation
- NR 580 Week 3: Comprehensive Case Write-Up
- NR 580 Week 5: Gap Analysis
- NR 580 Week 6: Self-assessment Write-up
- NR 580 Week 7: Complex Case Synthesis
- NR 580 Week 8: Readiness Reflection
- NR 568 Week 4: Allopurinol in CKD Case Analysis
- NR 579 Week 4: Advance Care Planning Note
- NR 576 Week 4: Clinical Reasoning Write-Up
- NR 578 Week 4: Transition of Care Plan
NR 580 Week 4 questions, answered
How do I tell which decision is the load-bearing one?
Take each candidate out of the plan in turn and see what stops making sense. Most choices can be swapped with little consequence elsewhere. One of them usually sets the monitoring, the return interval and what the patient was told all at once, and that is the one worth a brief. If nothing changes when you remove a decision, it will not sustain the argument this genre wants.
How much of the patient belongs in the brief?
Less than feels comfortable. Only the findings this choice turns on earn a place, which often means leaving out material that was central to a full write-up. Instructors read the exclusions as evidence that the writer understands what the decision actually rests on, and a brief padded back out into a case report loses the quality it was set to demonstrate.
Can the brief defend a decision I now think was wrong?
It can, and those often read strongest, provided the defense is built from what was available when the choice was made. The reversal section then does real work, because the writer already knows which signal arrived and which dependent line broke first. What fails is a brief quietly reasoning from information that came later, which removes the judgment the assignment exists to assess.
Where can I find a free NR 580 Week 4 sample paper?
The full decision brief on deintensifying diabetes treatment for the 76-year-old who falls is on this page.
What does the chosen option cost in the NR 580 Week 4 brief?
A likely rise in the A1c, perhaps toward 8%, and some long-term protection against small-vessel complications, which the patient accepted in return for fewer low sugars and falls.